ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $71,789,000 | +74.4% | 772,423 | +11.8% | 0.02% | +61.5% |
Q3 2021 | $41,156,000 | +18.0% | 691,112 | +35.1% | 0.01% | +30.0% |
Q2 2021 | $34,885,000 | +19.6% | 511,497 | +21.7% | 0.01% | +11.1% |
Q1 2021 | $29,173,000 | -31.9% | 420,414 | -24.6% | 0.01% | -35.7% |
Q4 2020 | $42,824,000 | +1.0% | 557,382 | -1.7% | 0.01% | -12.5% |
Q3 2020 | $42,416,000 | +48.2% | 567,134 | +24.8% | 0.02% | +33.3% |
Q2 2020 | $28,617,000 | +21.0% | 454,598 | -19.3% | 0.01% | 0.0% |
Q1 2020 | $23,657,000 | +37.7% | 563,255 | +48.9% | 0.01% | +71.4% |
Q4 2019 | $17,182,000 | +11.3% | 378,279 | +12.1% | 0.01% | +16.7% |
Q3 2019 | $15,438,000 | -41.9% | 337,302 | -25.5% | 0.01% | -40.0% |
Q2 2019 | $26,560,000 | – | 453,010 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |